These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Review about Structure and Evaluation of Reactivators of Acetylcholinesterase Inhibited with Neurotoxic Organophosphorus Compounds. Figueroa-Villar JD; Petronilho EC; Kuca K; Franca TCC Curr Med Chem; 2021; 28(7):1422-1442. PubMed ID: 32334495 [TBL] [Abstract][Full Text] [Related]
5. Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants. Kovarik Z; Maček Hrvat N Neuropharmacology; 2020 Jul; 171():108111. PubMed ID: 32333945 [TBL] [Abstract][Full Text] [Related]
6. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes. Nichols RH; Chambers JE Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259 [TBL] [Abstract][Full Text] [Related]
7. Organophosphorus poisoning in animals and enzymatic antidotes. Poirier L; Jacquet P; Plener L; Masson P; Daudé D; Chabrière E Environ Sci Pollut Res Int; 2021 May; 28(20):25081-25106. PubMed ID: 29959732 [TBL] [Abstract][Full Text] [Related]
8. A theoretical expression for the protection associated with stoichiometric and catalytic scavengers in a single compartment model of organophosphorus poisoning. Sweeney RE; Maxwell DM Math Biosci; 2003 Feb; 181(2):133-43. PubMed ID: 12445758 [TBL] [Abstract][Full Text] [Related]
9. Rational design, synthesis, and evaluation of uncharged, "smart" bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase. Gorecki L; Gerlits O; Kong X; Cheng X; Blumenthal DK; Taylor P; Ballatore C; Kovalevsky A; Radić Z J Biol Chem; 2020 Mar; 295(13):4079-4092. PubMed ID: 32019865 [TBL] [Abstract][Full Text] [Related]
10. Comparison of inhibition kinetics of several organophosphates, including some nerve agent surrogates, using human erythrocyte and rat and mouse brain acetylcholinesterase. Coban A; Carr RL; Chambers HW; Willeford KO; Chambers JE Toxicol Lett; 2016 Apr; 248():39-45. PubMed ID: 26965078 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases. Maček Hrvat N; Kalisiak J; Šinko G; Radić Z; Sharpless KB; Taylor P; Kovarik Z Toxicol Lett; 2020 Mar; 321():83-89. PubMed ID: 31863869 [TBL] [Abstract][Full Text] [Related]
12. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. Jokanović M Toxicol Lett; 2009 Oct; 190(2):107-15. PubMed ID: 19651196 [TBL] [Abstract][Full Text] [Related]
13. The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM). Amend N; Thiermann H; Worek F; Wille T Toxicol Lett; 2019 Jun; 308():1-6. PubMed ID: 30858091 [TBL] [Abstract][Full Text] [Related]
14. No-observed-adverse-effect-level (NOAEL) assessment as an optimized dose of cholinesterase reactivators for the treatment of exposure to warfare nerve agents in mice. Trancart M; Hanak AS; Dambrune C; Madi M; Voros C; Baati R; Calas AG Chem Biol Interact; 2024 Apr; 392():110929. PubMed ID: 38417730 [TBL] [Abstract][Full Text] [Related]
15. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069 [TBL] [Abstract][Full Text] [Related]
16. Are the current commercially available oximes capable of reactivating acetylcholinesterase inhibited by the nerve agents of the A-series? Santos MC; Botelho FD; Gonçalves AS; Kitagawa DAS; Borges CVN; Carvalho-Silva T; Bernardo LB; Ferreira CN; Rodrigues RB; Ferreira Neto DC; Nepovimova E; Kuča K; LaPlante SR; Lima ALS; França TCC; Cavalcante SFA Arch Toxicol; 2022 Sep; 96(9):2559-2572. PubMed ID: 35666269 [TBL] [Abstract][Full Text] [Related]
17. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953 [TBL] [Abstract][Full Text] [Related]
18. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016). Gorecki L; Korabecny J; Musilek K; Nepovimova E; Malinak D; Kucera T; Dolezal R; Jun D; Soukup O; Kuca K Expert Opin Ther Pat; 2017 Sep; 27(9):971-985. PubMed ID: 28569609 [TBL] [Abstract][Full Text] [Related]
19. Assessing the Therapeutic and Toxicological Profile of Novel Acetylcholinesterase Reactivators: Value of Ramalho TC; de Castro AA; Leal DHS; Teixeira JP; da Cunha EFF; Kuca K Curr Med Chem; 2023; 30(36):4149-4166. PubMed ID: 36239718 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro. Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]